Ategra Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,222
Closed -$557K 67
2024
Q1
$557K Hold
4,222
0.25% 58
2023
Q4
$460K Sell
4,222
-1,510
-26% -$157K 0.2% 65
2023
Q3
$590K Sell
5,732
-682
-11% -$73.5K 0.32% 54
2023
Q2
$740K Buy
6,414
+1,167
+22% +$133K 0.4% 49
2023
Q1
$647K Sell
5,247
-2,034
-28% -$220K 0.36% 55
2022
Q4
$808K Sell
7,281
-2,864
-28% -$293K 0.41% 50
2022
Q3
$874K Sell
10,145
-13,127
-56% -$1.17M 0.45% 46
2022
Q2
$2.12M Sell
23,272
-962
-4% -$85.3K 1.08% 30
2022
Q1
$1.99M Buy
24,234
+1,204
+5% +$94.9K 0.87% 34
2021
Q4
$1.77M Buy
23,030
+5,716
+33% +$455K 0.77% 34
2021
Q3
$1.3M Buy
17,314
+13,995
+422% +$1.06M 0.62% 41
2021
Q2
$258K Buy
+3,319
New +$247K 0.13% 96
2021
Q1
Sell
-2,808
Closed -$219K 108
2020
Q4
$219K Buy
2,808
+4
+0.1% +$306 0.15% 90
2020
Q3
$222K Sell
2,804
-692
-20% -$54.2K 0.2% 81
2020
Q2
$258K Buy
3,496
+63
+2% +$4.74K 0.25% 75
2020
Q1
$252K Hold
3,433
0.3% 61
2019
Q4
$298K Hold
3,433
0.25% 73
2019
Q3
$276K Sell
3,433
-1,205
-26% -$96.6K 0.25% 77
2019
Q2
$371K Buy
4,638
+4,024
+655% +$308K 0.35% 66
2019
Q1
$274K Buy
+614
New +$45.9K 0.27% 77

Other funds holding MRK

Ategra Capital Management's MRK Position: Q2 2024 in Review

Ategra Capital Management sold out of Merck (MRK) in Q2 2024, closing a stake of 4,222 shares — an estimated $557K sold.

Ategra Capital Management first reported a position in MRK in Q1 2019 and held it in 20 quarters. The position peaked at $2.12M in Q2 2022. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Ategra Capital Management reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Ategra Capital Management sold 4,222 Merck shares in Q2 2024, an estimated $557K.
  • Ategra Capital Management first reported a position in Merck in Q1 2019 and held it in 20 quarters.
  • Ategra Capital Management's Merck position peaked at $2.12M in Q2 2022.
  • 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Ategra Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.